Molecular mechanism of alcoholic fatty liver

Indian Journal of Pharmacology

Volumn 44, Issue 3, 2012, Pages 299-303

  Rasineni, Karuna ^a   Casey, Carol A ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b VA NEBRASKA WESTERN IOWA HEALTH CARE SYSTEM   (United States)

Author keywords

adenosine monophosphate activated protein kinase; Adiponectin; alcohol; lipid droplets; steatosis fatty liver

Indexed keywords

ADIPONECTIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; FAT DROPLET; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VERY LOW DENSITY LIPOPROTEIN;

ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALCOHOL METABOLISM; ALCOHOLIC FATTY LIVER; ENZYME ACTIVATION; FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; HUMAN; LIPID METABOLISM; LIPID STORAGE; LIPOGENESIS; LIVER CIRRHOSIS; MORBIDITY; NONHUMAN; OXIDATION REDUCTION STATE; PATHOGENESIS; PUBLIC HEALTH PROBLEM; REVIEW; RISK FACTOR;

EID: 84861893389     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.96297     Document Type: Review

References (57)

1. The world health report -2002. Reducing risks, promoting healthy life. World Health Organization. 2002. Available from: http://www.who.int/whr/2002/en/ .
2. Sozio M, Crabb DW. Alcohol and lipid metabolism. Am J Physiol Endocrinol Metab 2008;295:E10-6.
3. French SW. Ethanol and hepatocellular injury. Clin Lab Med 1996;16:289-306.
4. Zhou Z, Wang L, Song Z, Lambert JC, McClain CJ, Kang YJ. A critical involvement of oxidative stress in acute alcohol-induced hepatic TNF-alpha production. Am J Pathol 2003;163:1137-46.
5. Crabb DW, Galli A, Fischer M, You M. Molecular mechanisms of alcohol fatty liver: Role of peroxisome proliferator-activated receptor a. Alcohol 2004;34:35-8.
6. Bataller R, Rombouts K, Altamirano J, Marra F. Fibrosis in alcoholic and nonalcoholic steatohepatitis. Best Pract Res Clin Gastroenterol 2011;25:231-44.
7. Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 2004;114:147-52.
8. Yip WW, Burt AD. Alcoholic liver disease. Semin Diagn Pathol 2006;23:149-60.
9. Fridman S. Stellate cell activation in alcoholic fibrosis-an overview. Alcohol Clin Exp Res 1999;23:904-10.
10. Gramenzi A, Caputo F, BisellI M, Kuria F, Loggi E, Andreone P, et al. Review article: Alcoholic liver disease-pathophysiological aspects and risk factors. Aliment Pharmacol Ther 2006;24:1151-61.
11. Savolainen VT, Liesto K, Mannikko A, Penttila A, Karhunen PJ. Alcohol consumption and alcoholic liver disease: Evidence of a threshold level of effects of ethanol. Alcohol Clin Exp Res 1993;17:1112-7.
12. Lelbach WK. Cirrhosis in the alcoholic and its relation to the volume of alcohol abuse. Ann N Y Acad Sci 1975;252:85-105.
13. Grant BF, Dufour MC, Harford TC. Epidemiology of alcoholic liver disease. Semin Liver Dis 1988;8:12-25.
14. Day CP, James OF. Steatohepatitis: A tale of two "hits"? Gastroenterology 1998;114:842-5.
15. Lieber CS. New pathway of ethanol metabolism in the liver. Gastroenterology 1970;59:930-7.
16. Lieber CS. Hepatic, metabolic and toxic effects of ethanol: 1991 update. Alcohol Clin Exp Res 1991;15:573-92.
17. Lieber CS, De Carli LM. Hepatotoxicity of ethanol. J Hepatol 1991;12:394-401.
18. Grunnet N, Kondrup J. The effect of ethanol on the beta-oxidation of fatty acids. Alcohol Clin Exp Res 1986;10:64S-8.
19. Min Y, David WC. Recent advances in alcoholic liver disease II. Minireview: Molecular mechanisms of alcoholic fatty liver. Am J Physiol Gastrointest Liver Physiol 2004;287:G1-6.
20. Brown MS, Goldstein JL. A proteolytic pathways that controls the cholesterol content of membranes, cells, and blood. Proc Natl Acad Sci U S A 1999;96:11041-8.
21. You M, Fischer M, Deeg MA, Crabb DW. Ethanol induces fatty acid pathways by activation of steroid regulatory element binding protein (SREBP). J Biol Chem 2002;277:29342-7.
22. Reddy JK, Hashimoto T. Peroxisomal ?-oxidation and peroxisome proliferatoractivated receptor a: An adaptive metabolic system. Annu Rev Nutr 2001;21: 193-230.
23. Evans RM, Barish GD, Wang YX. PPARs and the complex journey to obesity. Nat Med 2004;10:1-7.
24. Yu S, Rao S, Reddy JK. Peroxisome proliferator-activated receptors, fatty acid oxidation, steatohepatitis and hepatocarcinogenesis. Curr Mol Med 2003;3: 561-72.
25. Lee GY, Kim NH, Zhao ZS, Cha BS, Kim YS. Peroxisomal proliferator activated receptor- a activates transcription of the rat hepatic malonyl-CoA decarboxylase gene: A key regulation of malonyl-CoA level. Biochem J 2004;378:983-90.
26. Nanji AA, Dannenberg AJ, Jokelainen K, Bass NM. Alcoholic liver injury in the rat is associated with reduced expression of peroxisome proliferator-a (PPAR- a)- regulated genes and is ameliorated by PPAR-a activation. J Pharmacol Exp Ther 2004;310:417-24.
27. Galli A, Pinaire J, Fischer M, Dorris R, Crabb DW. The transcriptional and DNA binding activity of peroxisome proliferator activated receptor alpha is inhibited by ethanol metabolism. A novel mechanism for the development of ethanol-induced fatty liver. J Biol Chem 2001;276:68-75.
28. Tuma DJ, Hoffman T, Sorrell MF. The chemistry of acetaldehyde-protein adducts. Alcohol Alcohol Suppl 1991;1:271-6.
29. Tuma DJ, Casey CA. Dangerous by products of alcohol breakdown-focus on adducts. Alcohol Res Health 2003;27:285-90.
30. Berg AH, Combs TP, Scherer PE. ACRP30 / adiponectin: An adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 2002;13:84-9.
31. Xu A, Wang Y, Keshaw H, Xu LY, Lam KS, Cooper GJ. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest 2003;112:91-100.
32. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002;8:1288-95.
33. Yamauchi T, Kamon J, Waki H, Imai Y, Shimozawa N, Hioki K, et al. Globular adiponectin protected ob / ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J Biol Chem 2003;278:2461-8.
34. Bird GL, Sheron N, Goka AK, Alexander GJ, Williams RS. Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann Intern Med 1990;112:917-20.
35. Jordi C, Ramo B, Pau S, Pablo B, Rosa M, Montserrat M, et al. Hepatic expression of candidate genes in patients with alcoholic hepatitis: Correlation with disease severity. Gastroenterology 2009;136:687-97.
36. Long YC, Zierath JR. AMP-activated protein kinase signaling in metabolic regulation. J Clin Invest 2006;116:1776-83.
37. Winder WW, Hardie DG. AMP-activated protein kinase, a metabolic master switch: Possible roles in type 2 diabetes. Am J Physiol 1999;277:E1-10.
38. Abu-Elheiga L, Matzuk MM, Abo-Hashema KA, Wakil SJ. Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. Science 2001;291:2613-6.
39. Shklyaev S, Aslanidi G, Tennant M, Prima V, Kohlbrenner E, Kroutov V, et al. Sustained peripheral expression of transgene adiponectin offsets the development of diet-induced obesity in rats. Proc Natl Acad Sci U S A 2003;100:14217-22.
40. Sanders MJ, Grondin PO, Hegarty BD, Snowden MA, Carling D. Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade. Biochem J 2007;403:139-48.
41. Liangpunsakul S, Wou SE, Zeng Y, Ross RA, Jayaram HN, Crabb DW. Effect of ethanol on hydrogen peroxide-induced AMPK phosphorylation. Am J Physiol Gastrointest Liver Physiol 2008;295:G1173-81.
42. Garcia-Ruiz C, Colell A, Mari M, Albert M, Maria C, Carlos E, et al. Defective TNF-a mediated hepatocellular apoptosis and liver damage in acidic sphingomyelinase knockout mice. J Clin Invest 2003;111:197-208.
43. Michael WB. Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: Possible role in steatosis. Am J Physiol Gastrointest Liver Physiol 2006; 290:194-8.
44. Naoumova RP, Kim KD, Neuwirth C, Niththyananthan S, Rendell NB, Taylor GW, et al. Effect of chronic ethanol feeding on the hepatic secretion of very-low-density lipoproteins. Biochim Biophys Acta 1988;960:61-6.
45. Kusum KK, Sandra LT, Brian WW, John JC. Dean JT. Betaine administration corrects ethanol-induced defective VLDL secretion. Mol Cell Biochem 2009;327:75-8.
46. Benita LM, Karuna R, Dean JT, Mark AM, Carol AC. Lipid Droplet Accumulation and Impaired Fat Efflux in Polarized Hepatic Cells: Consequences of Ethanol Metabolism. Int J Hepatol 2012;2012: ID 978136.
47. Wehr H, Rodo M, Lieber CS, Baraona E. Acetaldehyde adducts and autoantibodies against VLDL and LDL in alcoholics. J Lipid Res 1993;34:1237-44.
48. Brown DA. Lipid droplets: Proteins floating on a pool of fat. Curr Biol 2001; 11:R446-9.
49. Bartz R, Zehmer JK, Zhu M, Chen Y, Serrero G, Zhao Y, et al. Dynamic activity of Cite this article as: Rasineni K, Casey CA. Molecular mechanism of alcoholic fatty liver. Indian J Pharmacol 2012;44:299-303
50. Source of Support: Department of Veterans' Affairs, and the NIH (5RC1 AA019032). Conflict of Interest: None declared. lipid droplets: Protein phosphorylation and GTP-mediated protein translocation. J Proteome Res 2007;6:3256-65.
51. Brasaemle DL. The perilipin family of structural lipid droplet proteins: Stabilization of lipid droplets and control of lipolysis. J Lipid Res 2007;48:2547-59.
52. Robenek H, Hofnagel O, Buers I, Robenek MJ, Troyer D, Severs NJ. Adipophilinenriched domains in the ER membrane are sites of lipid droplet biogenesis. J Cell Sci 2006;119:4215-24.
53. Wolins NE, Brasaemle DL, Bickel PE. A proposed model of fat packaging by exchangeable lipid droplet proteins. FEBS Lett 2006;580:5484-91.
54. Listenberger LL, Ostermeyer-Fay AG, Goldberg EB, Brown WJ, Brown DA. Adipocyte differentiation-related protein reduces lipid droplet association of adipose triglyceride lipase and slows triglycerol turnover. J Lipid Res 2007;48:2751-61.
55. Martinez-Botas J, Anderson JB, Tessier D, Lapillonne A, Chang BH, Quast MJ, et al. absence of perilipin results in leanness and reverse obesity in Lepr(db/db) mice. Nat Genet 2000;26:474-9.
56. Tansy JT, Sztalryd C, Gruia-Gray J, Roush DL, Zee JV, Gavrilova O, et al. Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to diet-induced obesity. Proc Natl Acad Sci U S-Rfaut 2001;98:6494-9.
57. Mak KM, Ren C, Ponomarenko A, Cao Q, Lieber CS. Adipose differentiationrelated protein is a reliable lipid droplet marker in alcoholic fatty liver of rats. Alcohol Clin Exp Res 2008;32:683-9.